Atorlip 5: Effective Cholesterol Management for Cardiovascular Health
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.62 | $36.98 (0%) | 🛒 Add to cart |
| 90 | $0.52 | $55.47 $46.44 (16%) | 🛒 Add to cart |
| 120 | $0.47 | $73.96 $56.76 (23%) | 🛒 Add to cart |
| 180 | $0.42 | $110.94 $75.68 (32%) | 🛒 Add to cart |
| 270 | $0.39 | $166.41 $105.78 (36%) | 🛒 Add to cart |
| 360 | $0.38
Best per pill | $221.88 $135.02 (39%) | 🛒 Add to cart |
Similar products
Atorlip 5 contains atorvastatin calcium, a potent lipid-lowering medication belonging to the statin class. It is specifically formulated to reduce elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides in the blood, while also increasing high-density lipoprotein (HDL) cholesterol. By inhibiting HMG-CoA reductase, a key enzyme in cholesterol synthesis in the liver, Atorlip 5 helps manage hyperlipidemia and mitigate the risk of atherosclerotic cardiovascular disease. This medication is commonly prescribed as part of a comprehensive treatment plan that includes dietary modifications, physical activity, and other lifestyle adjustments. Clinical evidence supports its role in primary and secondary prevention of cardiovascular events.
Features
- Active ingredient: Atorvastatin calcium 5mg
- Pharmaceutical form: Film-coated tablets
- Mechanism: Selective, competitive inhibitor of HMG-CoA reductase
- Bioavailability: Approximately 14%
- Half-life: 14 hours; active metabolites contribute to prolonged effect
- Excretion: Primarily via hepatic metabolism and biliary elimination
Benefits
- Significantly lowers LDL cholesterol levels, reducing plaque buildup in arteries
- Decreases risk of myocardial infarction, stroke, and revascularization procedures
- Improves overall lipid profile by reducing triglycerides and modestly raising HDL cholesterol
- Offers flexible dosing within the therapeutic range for individualized treatment
- Supported by extensive clinical trial data demonstrating cardiovascular risk reduction
- Contributes to long-term vascular health when used as part of a managed treatment plan
Common use
Atorlip 5 is indicated as an adjunct to diet for the reduction of elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia (including heterozygous familial hypercholesterolemia) and mixed dyslipidemia. It is also used to slow the progression of atherosclerosis in adult patients with coronary heart disease and to reduce the risk of cardiovascular events such as heart attack or stroke. It may be prescribed for pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia, following appropriate clinical evaluation.
Dosage and direction
The recommended starting dose for most patients is Atorlip 5 (5 mg) once daily. Dosage may be adjusted based on lipid-lowering response and therapeutic goals, with a maximum dose of 80 mg daily. Tablets should be taken orally, with or without food, at any time of day—though consistency in timing is advised. Liver function tests should be performed before initiation and periodically thereafter. Dose adjustments may be necessary in patients taking concomitant cytochrome P450 3A4 inhibitors or those with renal impairment. Not recommended in patients with active liver disease.
Precautions
- Liver enzyme abnormalities may occur; periodic monitoring of liver function is recommended.
- Patients should be advised to report unexplained muscle pain, tenderness, or weakness promptly.
- Use with caution in patients who consume substantial quantities of alcohol or have a history of liver disease.
- May increase HbA1c and fasting serum glucose levels; monitor patients with diabetes accordingly.
- Not recommended during pregnancy or in women planning to become pregnant due to potential fetal harm.
- Elderly patients may be at increased risk of myopathy; consider lower starting doses.
Contraindications
- Active liver disease or unexplained persistent elevations of serum transaminases
- Hypersensitivity to any component of this medication
- Pregnancy, breastfeeding, and in women of childbearing potential not using contraception
- Concomitant use with strong CYP3A4 inhibitors such as clarithromycin, itraconazole, or HIV protease inhibitors
Possible side effect
Common side effects may include headache, diarrhea, nausea, joint pain, and nasopharyngitis. Musculoskeletal side effects such as myalgia, arthralgia, and muscle spasms have been reported. Rare but serious adverse reactions include rhabdomyolysis with renal dysfunction, hepatotoxicity, and increased blood glucose levels. Some patients may experience hypersensitivity reactions, including rash and pruritus. Memory loss and confusion have been reported infrequently. Most side effects are mild and transient.
Drug interaction
Atorvastatin is metabolized by CYP3A4; concomitant use with strong inhibitors (e.g., clarithromycin, ketoconazole, ritonavir) may increase atorvastatin exposure and risk of myopathy. Use with cyclosporine, gemfibrozil, or niacin may also increase myopathy risk. May interact with oral contraceptives, warfarin (monitor INR), and digoxin. Antacids and colestipol may reduce atorvastatin bioavailability. Caution advised with other lipid-lowering agents or erythromycin.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Do not take a double dose to make up for a missed one.
Overdose
There is no specific antidote for atorvastatin overdose. Treatment should be supportive and symptomatic. In cases of recent ingestion, gastric lavage may be considered. Monitor for signs of myopathy or renal injury, and provide appropriate hydration and supportive care. Hemodialysis is not expected to significantly enhance elimination.
Storage
Store at room temperature (15–30°C) in a dry place, protected from light and moisture. Keep in the original container, tightly closed. Do not use after the expiration date printed on the packaging. Keep out of reach of children and pets.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Do not disregard or delay seeking medical advice based on content provided here. Individual patient needs and responses may vary.
Reviews
(Simulated patient feedback based on clinical outcomes and typical user reports)
- “After six months on Atorlip 5, my LDL dropped by 38% with no significant side effects. Easy to tolerate and effective.”
- “My cardiologist prescribed this alongside dietary changes. Noticeable improvement in lipid panel within 8 weeks.”
- “Experienced mild muscle stiffness initially, but it subsided. Cholesterol levels are now within target range.”
- “A straightforward, low-dose option that integrated well with my diabetes management plan.”
- “No issues with compliance—once daily dosing is convenient. Annual bloodwork shows sustained benefits.”